Sanofi Business Development at a Glance

Last Updated: July 12th, 2019


Sanofi
Company Type: Large Pharma
Region: France, Worldwide
Cash Position: EUR 6,925M
Therapeutic Focus: Diabetes and Cardiovascular Diseases, Oncology, Immunology, Multiple Sclerosis, Rare Diseases, Vaccines

Sanofi Stock


DEAL ACTIVITY

Sanofi Deal Volume

Figure 1. Sanofi Deal Volume by Year, 2014 through Present (July 2019)

Recent Deal Highlights:

Collaboration with Denali for RIPK1 Inhibitor Program (DNL747, DNL758)

  • Date: Nov 2018 (SOURCE)
  • Therapeutic Area: Neuroscience, Immunology
  • Total Size: USD 1,125M
  • Upfront: USD 125M

Collaboration with REVOLUTION Medicines for SHP2 Inhibitor Program (RMC-4630)

  • Date: Jul 2018 (SOURCE)
  • Therapeutic Area: Oncology
  • Total Size: USD 550M
  • Upfront: USD 50M

Collaboration with Principia Biopharma for BTK Inhibitor Program (PRN2246)

  • Date: Nov 2017 (SOURCE)
  • Therapeutic Area: Neuroscience, Immunology
  • Total Size: USD 805M
  • Upfront: USD 40M

RESEARCH AND DEVELOPMENT

Sanofi Pipeline

Figure 2. Sanofi R&D Pipeline at present (July 2019)

Clinical Progress Following Recent Deals:

Denali-partnered RIPK1 Inhibitor (DNL747)

REVOLUTION-partnered SHP2 Inhibitor (RMC-4630)

Principia-partnered BTK Inhibitor Program (PRN2246)


PARTNERING AREAS OF INTEREST

  • "We are a global life sciences company committed to pursuing pioneering, life-changing treatments that address unmet healthcare challenges. Innovative collaborations are one of the fulfilling ways we meet those goals and create value for all involved." (SOURCE)
  • Sanofi is interested in partnering in Rare Diseases, Neuroscience, Immunology, Oncology, Human Vaccines, Consumer Healthcare, Diabetes, Cardiovascular, and Digital Healthcare (SOURCE)

BUSINESS DEVELOPMENT TEAM

BD&L Inquiries:

         54 Rue La Bo├ętie
         75008 Paris
         France
         E-mail: Global_Partnering@sanofi.com
         Phone: +33 (0)1 53 77 40 00


GLOBAL AND U.S. HEADQUARTERS

  • Paris, France (Global Headquarters) (SOURCE)
  • Bridgewater, NJ (US Headquarters) (SOURCE)

Business profiles tailored to your asset.